As activation of RTKs is often essential in tumor cell growth and development, overexpression of C1GalT1, which changes RTK glycosylation and their sensitivity to ligand binding, is therefore likely involved in regulating RTK-mediated activity in cancer development. The gene discussed is C1GALT1; the disease is cancer.